High-powered chart breakouts – shares, ETFs and investment trusts

Accenture/ ACN  $236  MV: $150bn Employees: 500,000+ Next figures: 24 September  MV/ TO – 3.3x

“We delivered Q3 revenues in line with the range we provided only eight days after the global pandemic was declared, and we hit a new milestone of approximately 70pc in the new, a digital — which is digital, cloud and security. We delivered $11bn in new bookings, a 6pc increase over Q3 last year, which demonstrates the relevance of our services and our ability to sell in a remote everything world. We continue to invest in our business for the long-term, closing an additional $742m in strategic acquisitions for a total of $1.3bn year-to-date. We delivered operating margin expansion of 10 basis points and we continue to strengthen our balance sheet, closing the quarter with $6.4bn in cash.” 25 June 2020

Ashtead  AHT  2885p  MV: £13.2bn Next figures: 10 December MV/ TO – 2.8x

“Look to the medium term with confidence and this year as one of strong cash generation and strengthening our market position. Assuming there is no significant COVID-19 second wave leading to major market shutdowns, like we experienced earlier this year, we expect full-year group rental revenue to be down mid to high single digits when compared with last year on a constant currency basis. The benefit we derive from the diversity of our products, services and end markets, coupled with ongoing structural change, enables the board to look forward to a year with free cash flow in excess of £1bn, continued strengthening of our market position and the medium term with confidence.”

Beigene  BGNE  $273  MV: $24.8bn  Next figures: 5 November  MV/ TO – 73x

“BeiGene is evaluating tislelizumab in multiple phase 3 trials for the treatment of lung cancer. Our hope is to advance our broad tislelizumab development program in lung cancer to potentially improve treatment outcomes for the most prevalent cancer, both globally and in China. In addition to our phase 3 data on tislelizumab, we are glad to report that the pivotal phase 2 data of pamiparib in advanced ovarian cancer patients with BRCA1/2 mutations demonstrated high objective response rates in both platinum-sensitive and platinum-resistant subtypes, and we look forward to advancing pamiparib, which is currently under regulatory review in China.”

BOTB (Best of the Best)  BOTB  1800p MV: £169m Employees: 21 Next figures: 30 January  MV/ TO – 6.0x

“Trading for the year to date has been stronger than expected at the time of the company’s final results. The momentum that built through the previous financial year has been maintained, resulting in a strong performance for the first four months of the new financial year and is expected to continue. The board expects both revenue and profits for the year ended 30 April 2021 to be ahead of previous management expectations. The company also continues to reap the benefits of it’s transformation to a wholly online operation.”

Croda International  CRDA  6250p  MV: £8.1bn  Next figures: 23 February  MV/ TO – 6.0x

“The strength of Croda’s business model has been demonstrated during the challenging market conditions created by the COVID-19 pandemic. Whilst customer demand has inevitably been impacted by the crisis, the strength and breadth of our product portfolio across consumer and industrial markets, our global footprint and customer intimacy, together with our flexible, batch chemistry manufacturing model have all helped to reduce its impact. This has been reflected in Croda’s resilient performance, with only a modest reduction in sales, a resilient margin and healthy free cash flow. By focusing on the future during these challenging times, we can accelerate our strategic delivery to enhance future growth and profitability.”

Epam Systems  EPAM  $316  MV: $17.7bn Next figures: 4 November  MV/ TO -5.6x

“While some of the variability in our client behavior has reduced, we still believe it’s challenging to talk about our business outlook beyond the next quarter which Jason will cover right after. Similarly, as we shared with you during our previous earnings call, our key priorities remain unchanged. We will continue to protect our people and our financial position as well as to make continuous investment in our core capabilities and platform to be prepared for eventual comeback. We strongly believe our position as a leading provider of digital product and platform engineering services, combined with our integrated and maturing consulting expertise, is our key differentiator. That is why we are very confident in our ability to come out of this challenging time, be even more value and result-driven company and continue growing in post pandemic environment with 20pc plus rate.”

Experian  EXPN 3124p  MV: £28.4bn  Next figures: 17 November  MV/ TO – 7.11x

“Experian, the global information services company, today issues an update on its expectations for trading for the three months ending 30 September 2020. In July 2020, we stated that we expected organic revenue for Q2 FY21 would be in the range of flat to 5pc and that organic costs for the first half would be held broadly flat. Following stronger trading in July and August, we today revise our Q2 FY21 expectations. We now expect group organic revenue growth for the quarter to be in the range +3 to +5pc, helped by further strength in US mortgage (which we expect will contribute +3 percentage points to growth in Q2), strength in the services we provide to consumers, as well as due to the naturally resilient qualities of parts of our portfolio. With continued investment in our innovation agenda, we now expect organic growth in costs of between 2 and 3pc for the first half.”

Fiverr International  FVRR  $123  MV: $4.3bn  Next figures: 11 November  MV/TO – 24.1x

“The past few months have been one of the most productive and rewarding times in our company’s history. The strategies that we have put in place and our strong execution during the global pandemic is what has allowed us to achieve such an outstanding quarterly performance, with revenue growing 82pc year over year to reach $47.1m. This is the strongest quarterly growth we have had since 2012, and over $10m or nearly 30pc above the top end of our guidance. More and more businesses are transforming to digital-first using Fiverr, and more and more freelancers are provided with opportunities to generate income.”

Frontier Developments  FDEV 2535p  MV: £981m  Next figures: 5 February  MV/TO – 10.4x

“Nearly 60pc of revenue in FY20 was generated by Elite Dangerous, Planet Coaster and Jurassic World Evolution, illustrating the ongoing popularity of the company’s games, and the success of Frontier’s launch and nurture strategy in generating strong returns over many years. Over 10m base game units sold across our four titles as of 31 May 2020 (Elite Dangerous 3.5m, Planet Coaster 2.5m, Jurassic World Evolution 3.0m and Planet Zoo 1.0m). IP licence signed for annual releases of Formula 1® management games from 2022 onwards.IP licence signed with Games Workshop for a real‐time strategy game based on the popular Warhammer Age of Sigmar brand. Frontier Foundry, our own games label for third‐party publishing, started strongly with six games signed to date, including one already released, one more announced and more coming soon. Two major new multi‐platform internally‐developed game releases scheduled for each of FY22 and FY23, each benefitting from world class IP licences.”

Games Workshop  GAW  10100p  MV: £3.3bn Next figures: 14 January  MV/TO – 10.9x

“In advance of our AGM on 16 September 2020, Games Workshop Group PLC announces today that trading for the three months to 30 August 2020 was ahead of the board’s expectations. Current estimates show sales of c. £90m in the period against a prior year of £78m for the same period. Operating profit for the period before royalty income is estimated to be c. £45m (2019: £28m) and royalty income is estimated to be c. £3m (2019: £2m). This has been driven by healthy growth in our online and trade channels. However, our retail channel is still recovering from the COVID-19 closures earlier in 2020. The longer term impact on the group as a result of the ongoing pandemic is still unknown.”

Globant  GLOB $177  MV: $7bn  Next figures: 12 November  MV/TO – 8.9x

“This year has accelerated the need for digital transformation across all industries and regions and the need will continue to grow. As MarketsandMarkets reports, the industry for digital transformation is expected to double from the current values to more than $1 trillion a year by 2025. Here at Globant I’m excited to say that this has been another successful quarter for us. As we champion the drive for digital and cognitive transformations, companies continue to respond. In quarter two, we brought in $182.7m in revenue, delivering 16pc year-over-year growth. We know that much uncertainty remains on the road ahead for everyone. But we also know that we face a unique opportunity. COVID-19 tested us in new ways. And from day one I told our Globers that we needed to be closer to our clients than ever. We’re determined to emerge from this situation, much stronger than before.”

Horizon Therapeutics  HZNP  $79.50  MV: $16.9bn Next figures: 9 November  MV/TO – 9.2x

“We delivered fantastic results this quarter, driven by the continued outperformance of TEPEZZA, our medicine we launched earlier this year for Thyroid Eye Disease or TED. We continue to hear from our stakeholders that TEPEZZA is meeting a significant and critical need for so many patients, who’ve gone years without any FDA-approved options to treat this painful and vision-threatening, rare autoimmune disease. Based on the significant TEPEZZA demand, we are increasing our full year 2020 TEPEZZA net sales guidance to more than $650m, a substantial increase in the guidance of more than $200m we announced last quarter. Additionally, based on the faster uptick we are seeing for the medicine as well as its broad indication, we’re raising our TEPEZZA peak U.S. annual net sales estimate to more than $3bn. Driven by TEPEZZA, we’re also increasing our 2020 total company net sales guidance by more than 30pc to $1.85 billion to $1.9bn.”

Intertek  ITRK  6418p  MV: £10.3bn  Next figures: 3 March  MV/TO – 3.7x

“Over the first six months of the year, the group delivered a resilient revenue performance, a robust margin and strong cash flow reflecting the strengths of our business model in providing mission-critical services to companies around the world, our disciplined performance management and our strongly cash generative earnings model. We have announced an unchanged half year dividend of 34.2p per share, based on our strong cash generation, robust balance sheet, the strength of our earnings model and our confidence in the group’s future growth opportunities. With our industry leading ATIC capability and expertise, innovation and insight, Intertek is uniquely positioned to seize these compelling growth opportunities. In short, the pandemic has brought to life as never before the importance of Intertek’s purpose-led role in society.”

Keywords Studios  KWS  2184p  MV: £1.6bn  Next figures: 16 April  MV/TO – 4.8x

“Our strong balance sheet and continued good cash generation places us in a strong position to continue our highly successful acquisition strategy as we selectively welcome new companies into the Keywords family. The growth drivers across our underlying video games market remain intact and we anticipate continued strong demand across all our service lines, including some pent-up demand from our clients as our operating environment continues to normalise. As governments around the world ease support measures for the unemployed or furloughed workers, we expect to be better able to recruit at the entry level positions that fuel growth in our testing and player support businesses. We believe Keywords will be seen as an even more attractive employer, with a hybrid model of remote and socially distanced, in-studio working in a thriving interactive entertainment sector.”

Spirax-Sarco  SPX 10685p  MV: £7.9bn Next figures:11 March  MV/TO – 6.6x

“With 85pc of our demand coming from customers’ operating rather than capital budgets and a high proportion of our revenues from sectors less impacted by COVID-19 such as Food & Beverage, Pharmaceutical & Biotechnology, Healthcare, Medical Devices, Power Generation and Water Treatment, we remain confident of our ability to progress in these unprecedented times. Spirax-Sarco Engineering plc is a multinational industrial engineering Group with expertise in the control and management of steam, electric thermal solutions, peristaltic pumping and associated fluid path technologies. Our technologies play a critical role across multiple industries from food and beverage to pharmaceuticals, power generation to paper production. With customers in 130 countries, wherever you live in the world we provide the engineered solutions that sit behind the production of many of the items you use every day.”

Team17  TM17  698p  MV: £903m  Next figures: 10 March  MV/TO –

“2020 was always going to be a memorable year for myself and many at Team17. This year we celebrate our 30^th anniversary and also the 25^th anniversary for our beloved Worms franchise. I’m delighted to share yet another record start to our fiscal year from the Group in the first half of 2020. Our broad genre and platform agnostic portfolio shows the importance of inclusivity and variety in gaming. Be it at home with your family or online with our growing community across the globe, from single player or local co-op to massive online games, we truly have an exceptional portfolio that encourages more gamers than ever before to step into the worlds we create and enjoy our characters. We live the world of video games, it’s part of everything we do here at Team17 be it creating our worlds, introducing new characters or bringing communities together. None of this would be possible without our talented and growing team. I would like to say a special thank you to our Teamsters and label partners for their continued resilience, ingenuity and brilliance as we grow together to deliver our personal and corporate ambitions.”

Tesla  TSLA  $443 MV: $412bn  Next figures: 27 October  MV/TO:

“We were able to achieve our fourth consecutive profitable quarter. And although the automotive industry was down about 30% year over year in the first half of the year, we managed to grow deliveries in the first half of the year. So despite that massive industry decline, we actually went up. We’re also very excited to announce that we’re going to be building our next Gigafactory in Texas. We’ll continue to grow in California, but we’ll be creating a massive factory and Cybertruck and Semi programs in Texas. I’m very confident about its Full Self-Driving functionality being complete by the end of this year. In the next 12 to 18 months, we’ll have three new factories in place. Things are looking great with Giga Berlin, and we’ll have Cybertruck, Semi, Roadster, Full Self-Driving. There’s so much to be excited about. I think I’ve never been more optimistic or excited about the future of Tesla and the history of the company.”

Zoom Video Communications  ZM $438  MV: $124bn  Employees:   Next figures: 5 December  MV/TO: 52.1x

“As remote work trends have accelerated during the pandemic, organizations have moved beyond addressing immediate business continuity needs to actively redefining and embracing new approaches to support a future of working anywhere, learning anywhere and connecting anywhere, and we continued to see meaningful adoption of Zoom’s video-first unified communication platform across industries and geographies. Revenue grew 355pc year-over-year in Q2. Customers with more than 10 employees grew 458pc year-over-year as new customers chose Zoom to be their preferred communication and collaboration solutions, and we had over 35,000 educators, school administrators, and IT professionals from around the world join our free virtual Zoom Summer Academy.”